We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

3 hedge funds and large institutions have $3.27K invested in Taro Pharmaceutical Industries Ltd. in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more capital invested

Capital invested by funds: $3.27K → $3.27K ($0)

50% less funds holding

Funds holding: 6 → 3 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
3
Holders Change
-3
Holders Change %
-50%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

TARO Hedge Fund Activity: Q4 2024 in Review

3 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q4 2024, worth a combined $3.27K — unchanged from a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of TARO and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

  • 3 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q4 2024, down from 6 in Q3 2024.
  • Funds reported $3.27K of Taro Pharmaceutical Industries Ltd. stock for Q4 2024, unchanged quarter-over-quarter.
  • 1 fund opened new Taro Pharmaceutical Industries Ltd. positions in Q4 2024 and 4 closed out, a net change of -3 holders.

Based on aggregated 13F filings for Q4 2024.